-
A batch of blockbuster first generic drugs are launched: CSPC, Hengrui, Haisco...
Time of Update: 2021-04-14
Medical Network News, April 2nd, less than ten days, a number of first imitation blockbuster listing CSPC's first imitation approved On April 1, CSPC announced that the “Amphotericin B Cholesterol Sulfate Complex for Injection” developed by its subsidiary CSPC Ouyi Pharmaceutical Co.
-
The state ordered!
Time of Update: 2021-04-14
Medical News, April 1st. On March 26th, the State Drug Administration issued the "Notice of the Comprehensive Department of the State Drug Administration on Carrying out the Inspection and Treatment
-
Yangtze River Health: Ceftazidime for injection in its subsidiary passed the consistency evaluation
Time of Update: 2021-04-14
Ceftazidime for injection belongs to the third-generation cephalosporin antibiotic.
It also has a good antibacterial effect against nitrate-negative bacilli and Alcaligenes.
Ceftazidime for injection is a commonly used third-generation cephalosporin drug in clinical practice, and the two specifications of 0.
-
Huadong Medicine Class 1 biopharmaceutical IMGN853 was approved for clinical use
Time of Update: 2021-04-14
IMGN853 is an antibody-drug conjugate (ADC) targeting FRα developed by ImmunoGen of the United States.
This product is the world's first ADC drug under development for FRα-positive ovarian cancer.
It is used to treat platinum-resistant ovarian cancer with high folate receptor expression.
-
Orthopedics trauma, 10 province alliance, the next round of national mining "new rules" is ready to come out
Time of Update: 2021-04-14
Medical Network News on March 31 Centralized collection of orthopedic trauma in the ten-province alliance, the highest drop was 94% On March 26, the Henan Provincial Medical Insurance Bureau issued the "Notice on Carrying out the Procurement of Related Manufacturing Enterprise Product Information by the Ten Provinces (Autonomous Regions, Municipalities) Orthopedic Trauma Medical Consumables Alliance".
-
Zhengda Tianqing, Qilu, Hausen... Siege 700 million anti-tumor drugs!
Time of Update: 2021-04-14
Sales of terminal lenalidomide capsules in Chinese public medical institutions in recent years Source: Terminal competition landscape of China's public medical institutions According to data from Menet.
-
Which of the various new formulations such as the new crown vaccine nasal spray will succeed?
Time of Update: 2021-04-14
This vaccine will be delivered as a nasal spray directly to the human respiratory tract, where the SARS-CoV-2 virus may invade and reproduce (the lungs and upper respiratory tract, etc.
In addition, vaccine components that use bacteria as carriers can deliver antigens directly to the mucosal tissues of the nose and oral cavity.
-
John C. Martin, former CEO and chairman of Gilead, dies
Time of Update: 2021-04-14
Although John Martin has left us, the scientific progress he has made under his leadership and the innovative breakthrough therapy that benefited patients around the world will be remembered forever by future generations.
-
Yangtze River's leading chemical drug brand TOP10!
Time of Update: 2021-04-14
Sales of Anlotinib Capsules in Recent Years Source: Competitive pattern of chemical medicine terminal in public hospitals of key provinces and cities Anlotinib Hydrochloride Capsules is a new class 1 anti-tumor drug developed by Chia Tai Tianqing Pharmaceutical Group, a subsidiary of China Biopharmaceuticals.
-
The blockbuster policy of Chinese medicine is coming, and the entire chain of listed chains has become popular
Time of Update: 2021-04-14
Medical News, April 1st, 30th, the listed chain has an eye-catching performance in the capital market. As of today's close, Yixintang has risen as much as 8. 98%. This is the most obvious signal th
-
A number of well-known pharmaceutical company executives leave the market to promote transformation
Time of Update: 2021-04-14
The market promotes transformation, and executives change frequently From the perspective of position, deputy general managers and vice presidents are the positions that senior executives of domestic pharmaceutical companies resign intensively; from the perspective of the reasons for resignation, it is mainly due to "personal reasons", followed by "work reasons.
-
20 types of inhalants are amazing!
Time of Update: 2021-04-14
TOP20 inhalants released, three major products rose against the trend According to data from Mi Nei. com, the market size of terminal inhalants in public hospitals in key provinces and cities has expanded year by year, and the annual growth rate has remained at double digits.
-
The resignation of the chairman of Weigao shares takes effect two major businesses or splits!
Time of Update: 2021-04-14
Medical News, April 1st, Zhang Huawei resigned, Long Jing has been appointed Chairman's resignation has taken effect On March 30, Weigao Co.
Medical News, April 1st, Zhang Huawei resigned, Long Jing has been appointed Chairman's resignation has taken effect On March 30, Weigao Co.
-
EMA accepts Bristol-Myers Squibb Opdivo Class II change application
Time of Update: 2021-04-14
The results showed that: (1) In all randomized patients (ITT), compared with placebo, adjuvant Opdivo treatment almost doubled the disease-free survival: the median DFS in the placebo group was 10.
-
CSPC's Amphotericin B Cholesterol Sulfate Complex is about to be approved
Time of Update: 2021-04-14
On March 29, the official website of NMPA showed that the listing application (acceptance number: CYHS1900072) of CSPC’s 4 generic drugs "Amphotericin B Cholesterol Sulfate Complex for Injection" was changed to "Under Approval".
-
The second batch of key monitoring, key attention drug list release
Time of Update: 2021-04-14
List of the second batch of key monitored drugs in Fujian Province: List of the second batch of key drugs in Fujian Province: Medical Network, April 1st.
-
Innovative FGFR inhibitor futibatinib received FDA breakthrough therapy designation
Time of Update: 2021-04-14
Today, Taiho Pharmaceutical and its subsidiary Taiho Oncology announced that the US FDA has granted the irreversible FGFR oral inhibitor futibatinib (TAS-120) breakthrough therapy designation for the treatment of locally advanced or metastatic cholangiocarcinoma (cholangiocarcinoma).
-
Beijing Shuanglu Pharmaceutical Adefovir Dipivoxil Tablets Passed the Consistency Evaluation
Time of Update: 2021-04-14
In addition, for patients who develop resistance or poor response to lamivudine, telbivudine, or entecavir, adefovir dipivoxil can be added because adefovir does not have a cross-resistance site with the above 3 drugs Combination therapy.
-
Hidden worries in the development of volume procurement: supply cuts, medium-sized enterprises out, procurement fragmentation...
Time of Update: 2021-04-14
Pharmaceutical companies are busy dealing with various centralized procurement projects, not to mention which products will be included in the future, just say that after the selection, the supply of enterprises and the clinical replacement of hospitals, are all these smooth?
-
What is the human intestinal micro-ecosystem, follow Yibeishi to see
Time of Update: 2021-04-14
This type of flora mainly helps our intestines to work in an orderly manner, inhibits the growth of harmful bacteria, maintains the intestinal balance, and protects human health.
Understand the human intestinal micro-ecology, and use lifespace probiotic solid beverages to better protect intestinal health.
